| Gene symbol | MSLN | Synonyms | MPF, SMRP | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mesothelin | ||||
| GTO ID | GTC0477 |
| Trial ID | NCT03907852 |
| Disease | Cholangiocarcinoma | Mesothelioma | Ovarian Cancer |
| Altered gene | Mesothelin |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | Gavocabtagene Autoleucel|Gavo-cel|TC-210 |
| Co-treatment | Nivolumab|Ipilimumab |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Phase 1/2 Single Arm Open-Label Clinical Trial of Gavocabtagene Autoleucel (Gavo-cel) in Patients With Advanced Mesothelin-Expressing Cancer |
| Year | 2019 |
| Country | United States |
| Company sponsor | TCR2 Therapeutics |
| Other ID(s) | TCR2-18-01 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||